Skip To Main Content
Tamieka Fraser on Muck Rack

Tamieka Fraser

As seen in: British Journal of Cancer, Microbiology Research
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tamieka

Contact Tamieka, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Search Results

|
By Erin Price, Timothy J. Kidd, Tamieka Fraser
| Microbiology Research
Background. Antimicrobial resistance (AMR) is an ever-increasing global health concern. One crucial facet in tackling the AMR epidemic is earlier and more accurate AMR diagnosis, particularly in the dangerous and highly multi-drug-resistant ESKAPE pathogen, Pseudomonas aeruginosa . Objectives. We aimed to develop two SYBR Green-based mismatch amplification mutation assays (SYBR-MAMAs) targeting GyrA T83I (gyrA248) and GyrA D87N, D87Y and D87H (gyrA259).
Open in Who Shared Issue with article?

Chlamydia Serine Protease Inhibitor, targeting HtrA, as a New Treatment for Koala Chlamydia infection

|
By Biomedical Innovation, Amber Gillett, Amba Lawrence, Tamieka Fraser
| British Journal of Cancer Verified
Our previous work suggested that JO146 was most efficacious when added during the mid-replicative growth phase of C. trachomatis22. However, there are no published growth curves for koala Chlamydia isolates so we first needed to profile the growth of these isolates in order to subsequently evaluate inhibitor activity. Growth curves were conducted for urogenital isolates C. pecorum MarsBar and C. pecorum DBDeUG, and ocular isolate C. pecorum IPTaLE23.
Open in Who Shared Issue with article?
See all 2 articles